Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs

16 Aug 2021

Abstract excerpt

Abstract Background Gastric cancer (GC) is a globally prevalent cancer, ranking fifth for incidence and fourth for mortality worldwide. The N6-methyladenosine (m6A) related long noncoding RNAs (lncRNAs) were widely investigated in recent studies. Nevertheless, the underlying prognostic implication and tumor immune mechanism of m6A-related lncRNA in GC remain unknown. Methods We systematically assessed the m6A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Cholangiocarcinoma and Gallbladder Cancer Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA modifications and cancer

Source

Identifiers

PMID: 34399770
DOI: 10.1186/s12935-021-02146-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAsPMID 34399770Read ↗

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patientsSemantic proximity Read ↗

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerSemantic proximity Read ↗

A m6A-related lncRNA Signature as a Novel Prognostic Factor for Gastric CancerSemantic proximity Read ↗

Novel M7G-Related lncRNA Signature for Predicting Overall Survival in Patients with Gastric CancerSemantic proximity Read ↗

N6-methyladenosine demethylase FTO serves as an indicator for predicting prognosis and immunotherapy response in individuals with gastric cancerSemantic proximity Read ↗

Analysis and Prognosis of Tumor Immune Infiltrates and Immune Microenvironment of m6A-Related LncRNAs in Patients with Gastric CancerSemantic proximity Read ↗

Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related lncRNAs in Gastric CancerSemantic proximity Read ↗

Prognostic signature and immune landscape of 5-methylcytosine-related long non-coding RNAs in gastric cancerSemantic proximity Read ↗

m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancerSemantic proximity Read ↗

Identification of Prognosis Signature and Analysis of the Immune Microenvironment in Gastric Cancer Based on ALKBH5Semantic proximity Read ↗

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancerSemantic proximity Read ↗

N‑methyladenosine reader YTHDF2‑mediated AC026691.1 degradation promotes gastric cancer cell proliferation, migration and M2 macrophage polarizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.